Georgia Tech researchers applied a different approach to their machine learning algorithm to predict what medications would best treat different ovarian cancers.
Healthcare leaders will want to follow the nascent field of sound wave therapy as more research and the findings of clinical trials emerge.
Precision Medicine Institute’s noted of liquid biopsy research, collaborations, and advancements as 2022 approaches year-end.
Where AI and molecular testing are showing new methods of detecting pancreatic cancers before they become more advanced.
More states are focusing on cancer biomarker testing for payer coverage requirements.
Recent research into liquid biopsies has resulted in a new blood test that can detect liver cancer while it is still in an early stage.
Hospitals and oncology groups may be able to apply modern precision medicine principles to a 50-year-old cancer drug, increasing the drug’s effectiveness for breast cancer patients.
Method genetically defines patients who would benefit from intensifying the chemotherapy, adding a new drug, or having chemotherapy reduced to avoid toxicity.
Researchers at Weill Cornell Medicine believe they have discovered the variant protein that causes taxane-resistant cancer cells to develop.
By using organoids, “we can show that for a particular patient subset, for a particular drug, we can do better than the current selection criteria,” stated Else Driehuis, PhD.
